Pharming Group N.V.
Stock Forecast, Prediction & Price Target
Pharming Group N.V. (PHAR) stock Price Target by analysts
$14
Potential upside: 10.14%
Pharming Group N.V. price prediction
What is Pharming Group N.V. stock analysts` prediction?
Pharming Group N.V. stock forecast: Based on 1 Wall Street analysts` predicted price targets for Pharming Group N.V. in the last 3 months, the avarage price target is $14, with a high forecast of $NaN. The average price target represents a 10.14% change from the last price of $12.71.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Pharming Group N.V. stock Price Target by analysts
Full breakdown of analysts given Pharming Group N.V. price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Lucy Codrington Jefferies | 0% 0/1 | 10 months ago | $14 10.14% upside | $7.72 | StreetInsider | Previous targets (0) |
Pharming Group N.V. Financial Estimates
Pharming Group N.V. Revenue Estimates
Pharming Group N.V. EBITDA Estimates
Pharming Group N.V. Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $189.85M N/A | $205.62M 8.30% | $245.31M 19.30% | Avg: $329.27M Low: $314.16M High: $341.07M avg. 34.22% | Avg: $377.02M Low: $365.36M High: $388.55M avg. 14.50% | Avg: $434.14M Low: $420.72M High: $447.42M avg. 15.15% | Avg: $419.91M Low: $406.93M High: $432.76M avg. -3.27% |
Net Income
% change YoY
| $15.99M N/A | $13.67M -14.51% | $-10.54M -177.13% | Avg: $-369.86K Low: $-1.29M High: $924.65K avg. 96.49% | Avg: $9.65M Low: $9.26M High: $10.04M avg. 2711.14% | Avg: $21.14M Low: $20.29M High: $21.98M avg. 118.93% | Avg: $37.60M Low: $36.09M High: $39.09M avg. 77.83% |
EBITDA
% change YoY
| $46.56M N/A | $32.60M -29.97% | $9.87M -69.70% | Avg: $78.62M Low: $75.01M High: $81.43M avg. 696.00% | Avg: $90.02M Low: $87.24M High: $92.77M avg. 14.50% | Avg: $103.66M Low: $100.45M High: $106.83M avg. 15.15% | Avg: $100.26M Low: $97.16M High: $103.33M avg. -3.27% |
EPS
% change YoY
| $0.25 N/A | $0.21 -16.00% | -$0.01 -106.90% | Avg: -$0.01 Low: -$0.02 High: $0.01 avg. 62.18% | Avg: $0.14 Low: $0.14 High: $0.15 avg. 2711.14% | Avg: $0.31 Low: $0.3 High: $0.33 avg. 118.93% | Avg: $0.56 Low: $0.54 High: $0.58 avg. 77.83% |
Operating Expenses
% change YoY
| $156.72M N/A | $169.82M 8.36% | $225.49M 32.77% | Avg: $140.72M Low: $134.27M High: $145.77M avg. -37.58% | Avg: $161.13M Low: $156.15M High: $166.06M avg. 14.50% | Avg: $185.55M Low: $179.81M High: $191.23M avg. 15.15% | Avg: $179.47M Low: $173.92M High: $184.96M avg. -3.27% |
FAQ
What is Pharming Group N.V. stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 751.10% in 2025-2028.
We have gathered data from 3 analysts. Their low estimate is -1.29M, average is -369.86K and high is 924.65K.
What is Pharming Group N.V. stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 15.14% in 2025-2028.
We have gathered data from 3 analysts. Their low revenue estimate is $314.16M, average is $329.27M and high is $341.07M.
What is Pharming Group N.V. stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 742.52% in 2025-2028.
We have gathered data from 3 analysts. Their low earnings per share estimate is -$0.02, average is -$0.01 and high is $0.01.
What is the best performing analyst?
In the last twelve months 1 analysts have been covering Pharming Group N.V. stock. The most successful analyst is Lucy Codrington.